Top compounds associated with response to RFXANK


Feature Type Standardized
Nominal ANOVA
mRNA dinaciclib CTRPv2 pan-cancer AAC 0.035 0.5
mRNA Nilotinib FIMM pan-cancer AAC -0.12 0.5
mRNA GW843682X CTRPv2 pan-cancer AAC 0.025 0.5
mRNA Panobinostat CCLE pan-cancer AAC -0.028 0.5
mRNA PD173074 GDSC1000 pan-cancer AAC 0.025 0.5
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.026 0.5
mRNA avrainvillamide CTRPv2 pan-cancer AAC -0.029 0.5
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.024 0.5
mRNA BI-2536 CTRPv2 pan-cancer AAC 0.022 0.5
mRNA AZD6482 GDSC1000 pan-cancer AAC 0.022 0.5
Download CSV